NEW

Philips to Acquire Capsule Technologies Inc.

Royal Philips has signed an agreement to acquire Capsule Technologies Inc., a provider of medical device integration and data technologies for hospitals and healthcare organizations.

Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

Cincinnati Sub-zero Electri-Cool II

Non-ice based cold therapy systems like the Cincinnati Sub-zero Electri-Cool II are becoming an alternative to traditional ice-based systems, which carry the risk of causing tissue and skin damage. This localized cold therapy system provides a more consistent cooling therapy by cycling continuous cold water through a pad to the patient at a therapeutic temperature that will not cause skin or tissue damage. And since there’s no ice, nurses don’t have to remember to change ice or deal with cleaning up wet floors.

The Electri-Cool II is lightweight and compact, and it can be attached to the patient’s bed with a bracket or mounted on a stand for easy mobility. Possible applications for the Electri-Cool II include surgical incision treatment, swelling from injury, sprains, strains and more. There are three levels of temperature for personalized patient comfort, and a variety of pads are available for different applications.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X